EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

Myriam Chalabi iD, Yara L Verschoor iD, Pedro Batista Tan, Sara Balduzzi, Anja U Van Lent, Cecile Grootscholten, Simone Dokter, Nikè V Büller, Brechtje A Grotenhuis, Koert Kuhlmann, Jacobus W Burger, Inge L Huibregtse und 12 weitere

New England Journal of Medicine · 06.06.2024 · 390 (21) · 1949-1958

DOI: 10.1056/nejmoa2400634 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 06.06.2024. Verfasst von Myriam Chalabi und 23 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Gastrointestinal Oncology (M.C., Y.L.V., P.B.T., C.G., S.D., N.V.B., I.L.H., M.E.V.L.), Medical Oncology (M.C., C.G., N.V.B.,…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Nivolumab. Die Arbeit wurde bisher 540-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Bristol Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsColonic NeoplasmsNivolumabIpilimumabAntineoplastic Agents, ImmunologicalDNA Mismatch RepairAdultAged, 80 and overTime-to-TreatmentFemaleHumansNetherlandsAgedEuropean PeopleMaleYoung AdultDisease-Free SurvivalMiddle Aged

Substanzen

IpilimumabNivolumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • From the Departments of Gastrointestinal Oncology (M.C., Y.L.V., P.B.T., C.G., S.D., N.V.B., I.L.H., M.E.V.L.), Medical Oncology (M.C., C.G., N.V.B., E.E.V., J.B.H.), Biometrics (S.B.), Surgery (B.A.G., K.K., G.L.B.), P…

ORCID-Profile: Myriam Chalabi, Yara L Verschoor

Förderung

  • Bristol Myers Squibb

Zitieren

APA

Chalabi, M., Verschoor, Y. L., Tan, P. B., Balduzzi, S., Van Lent, A. U., Grootscholten, C., Dokter, S., Büller, N. V., Grotenhuis, B. A., Kuhlmann, K., Burger, J. W., Huibregtse, I. L., Aukema, T. S., Hendriks, E. R., Oosterling, S. J., Snaebjornsson, P., Voest, E. E., Wessels, L. F., Beets-Tan, R. G., …, & Haanen, J. B. (2024). Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer. New England Journal of Medicine, 390(21), 1949-1958. https://doi.org/10.1056/nejmoa2400634

Vancouver

Chalabi M, Verschoor YL, Tan PB, Balduzzi S, Van Lent AU, Grootscholten C, et al. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer. New England Journal of Medicine. 2024;390(21):1949-1958. doi:10.1056/nejmoa2400634

BibTeX
@article{Chalabi2024,
  author = {Chalabi, Myriam and Verschoor, Yara L and Tan, Pedro Batista and Balduzzi, Sara and Van Lent, Anja U and Grootscholten, Cecile and Dokter, Simone and Büller, Nikè V and Grotenhuis, Brechtje A and Kuhlmann, Koert and Burger, Jacobus W and Huibregtse, Inge L and Aukema, Tjeerd S and Hendriks, Eduard R and Oosterling, Steven J and Snaebjornsson, Petur and Voest, Emile E and Wessels, Lodewyk F and Beets-Tan, Regina G and Van Leerdam, Monique E and Schumacher, Ton N and van den Berg, José G and Beets, Geerard L and Haanen, John B},
  title = {Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {21},
  pages = {1949--1958},
  doi = {10.1056/nejmoa2400634}
}
Kostenlos starten →